4.6 Article

Integration of Mendelian randomisation and systems biology models to identify novel blood-based biomarkers for stroke

Journal

JOURNAL OF BIOMEDICAL INFORMATICS
Volume 141, Issue -, Pages -

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.jbi.2023.104345

Keywords

Stroke; Genome-wide association studies; Expression quantitative trait loci; DNA methylation quantitative trait loci; Summary data-based Mendelian randomisation; DNA methylation; Gene expression

Ask authors/readers for more resources

This study aimed to identify putative functional causal gene biomarkers of stroke risk using a summary-based Mendelian randomisation (SMR) approach. Through integrative analysis, 45 candidate biomarker genes were identified that were pleiotropically or potentially causally associated with stroke risk. Among them, 10 genes exhibited differential expression in blood transcriptomics data from stroke and healthy individuals. This study provides insights into the influence of DNA methylation on the expression of genes linked to stroke risk.
Stroke is the second largest cause of mortality in the world. Genome-wide association studies (GWAS) have identified some genetic variants associated with stroke risk, but their putative functional causal genes are unknown. Hence, we aimed to identify putative functional causal gene biomarkers of stroke risk. We used a summary-based Mendelian randomisation (SMR) approach to identify the pleiotropic associations of genetically regulated traits (i.e., gene expression and DNA methylation) with stroke risk. Using SMR approach, we integrated cis-expression quantitative loci (cis-eQTLs) and cis-methylation quantitative loci (cis-mQTLs) data with GWAS summary statistics of stroke. We also utilised heterogeneity in dependent instruments (HEIDI) test to distinguish pleiotropy from linkage from the observed associations identified through SMR analysis. Our integrative SMR analyses and HEIDI test revealed 45 candidate biomarker genes (FDR < 0.05; PHEIDI > 0.01) that were pleiotropically or potentially causally associated with stroke risk. Of those candidate biomarker genes, 10 genes (HTRA1, PMF1, FBN2, C9orf84, COL4A1, BAG4, NEK6, SH2B3, SH3PXD2A, ACAD10) were differentially expressed in genome-wide blood transcriptomics data from stroke and healthy individuals (FDR < 0.05). Functional enrichment analysis of the identified candidate biomarker genes revealed gene ontologies and pathways involved in stroke, including cell aging, metal ion binding and oxidative damage. Based on the evidence of genetically regulated expression of genes through SMR and directly measured expression of genes in blood, our integrative analysis suggests ten genes as blood biomarkers of stroke risk. Furthermore, our study provides a better understanding of the influence of DNA methylation on the expression of genes linked to stroke risk.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available